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ABSTRACT 
Int J Exerc Sci 5(1) : 26-38, 2012. The present study was designed to examine the relationship 
between homocyst(e)ine (H[e]) levels and muscle mass. Two experimental groups each of 24 
Caucasian males, one consisting of higher-muscle mass subjects (HMM) and the other of lower-
muscle mass subjects (LMM) par-ticipated in this study. Muscle mass was estimated from 24-
hour urine collections of creatinine (Crt). Muscle mass was 40.3 ± 15.9 kg in HMM and 37.2 ± 11.4 
kg in LMM (P= 0.002). Mean plasma H(e) levels in HMM were 10.29 ± 2.9 nmol/mL, and in LMM 
were 10.02 ± 2.4 nmol/L (Not significant, [NS]). Urinary H(e) levels (UH[e]) were 9.95 ± 4.3 
nmol/mL and 9.22 ± 2.9 nmol/mL for HMM and LMM, respectively (NS). Plasma H(e) levels 
correlated well with UH(e) (HMM: r= 0.58, P= 0.009; LMM: r= 0.66, P= 0.004). Muscle mass and 
was not correlated to either plasma H(e) or UH(e). However, in HMM trends were identified for 
body mass to be cor-related with UH(e) (r= 0.39, P= 0.10) and UCrt (r= 0.41, P= 0.08). 
Surprisingly, in HMM plasma and UCrt were only weakly correlated (r= 0.44, P= 0.06). Our 
results do not support a causal relationship between the amount of muscle mass and H(e) levels 
in plasma or urine. 
 
KEY WORDS: Creatinine, homocysteine, estrogen, gender-differences, skeletal 
muscle 
 
 
INTRODUCTION 
 
Today, atherosclerotic cardiovascular 
disease (CVD) is representing a leading 
cause of mortality in the United States (37) 
and many European countries (33). The risk 
factors are broadly the same for both 
genders: cigarette smoking, inactivity, high 
LDL cholesterol levels, hypertension, and 
diabetes (33, 37, 43, 48). One predictor of 
CVD that has received much attention since 
the 1990s is homocyst(e)ine (8, 42, 47). 
Homocyst(e)ine is an amino acid that is 
produced during the conversion of dietary 
protein into energy, a process which seems 
to damage the arteries (25, 40, 44). 
Homocyst(e)ine levels are higher in males 
than in females, and it has been speculated 
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that this might contribute to the overall 
higher incidence of CVD in men, when 
compared to women (3, 25, 26). Exactly 
why this gender-specific difference in 
homocyst(e)ine concentrations exists has 
long been the subject of considerable 
debate. 
 
Brattström et al. (6) have hypothesized that 
such sex-differences could be attributable to 
muscle mass. It is known that 
approximately 98% of creatinine is derived 
from creatine formed in the muscle, and 
that the amount of creatinine released is 
determined by muscle mass (38). The 
formation of creatine (from which 
creatinine proceeds) depends on the methyl 
donation by S-adenosylmethionine, a 
process which leads to the formation of 
homocysteine (2, 40). Mudd and Poole (32) 
and Brattström et al. (6), consequently, were 
able to demonstrate positive correlations 
between levels of homocyst(e)ine and 
plasma creatinine. These findings led these 
authors to opine that the homocysteine 
concentration too would be expected to 
reflect muscle mass as much as the 
creatinine concentration does, and 
speculated that this might be the reason 
why men will generally have higher 
concentrations of both creatinine and 
homocysteine (3, 13). 
 
However, the actual relationship between 
homocysteine and muscle mass itself has 
not been investigated sufficiently. The few 
studies that have looked into the 
relationship between both, have compared 
males and females hence having been 
confounded by many important factors 
such as particularly sex steroids and 
menstrual cycle fluctuations (10, 13). It 
therefore remains somewhat surprising that 
to date, to the best of our knowledge, no 
study has attempted to assess muscle mass 
effects on homocysteine levels in same-sex 
groups in order to exclude this major 
confounder represented by an estrogen- vs. 
a testosterone-rich environment. Thus, it is 
the purpose of the present study to 
investigate the possible role of muscle mass 
on plasma and urine homocyst(e)ine and 
creatinine levels in same-gender subjects 
(males). Our hypothesis is that differences 
in H(e) levels might be attributed to 
differences in muscle mass. In addition, we 
also wanted to see if muscle mass might 
affect the clearance of H(e). 
 
METHODS 
 
Participants 
All procedures of this study were 
conducted in compliance with institutional 
ethics procedures and expectations 
described in the Declaration of Helsinki. 
Following institutional ethics approval, 
subjects provided informed consent after 
the purpose and content of the experiments 
were carefully explained. Two different 
subject groups each consisting of 24 
Caucasian males, between 18-45 years, 
volunteered to participate in this study. 
Based upon effect sizes calculated from 
meta-analysis of other studies that have 
measured homocyst(e)ine in subjects of 
similar ages (26, 36, 42), the minimal 
required sample size in each group in order 
to maintain a statistical power of 0.8, was 
determined as 23. Subjects were assigned to 
either the higher (HMM) or the lower 
muscle mass group (LMM) based on the 
consideration that those subjects regularly 
engaging in weightlifting and resistance 
training would likely have more muscle 
mass than those only engaging in aerobic 
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running. To avoid subjects with more 
muscle mass being also heavier and 
therefore introducing an overall higher 
body mass as a confounder, we elected that 
subjects should be matched for body mass. 
HMM subjects engaged in weightlifting for 
at least 4 days per week for more than a 
year, whilst not engaging in regular aerobic 
exercise. Subjects in this experimental 
group all were members of a police riot 
squad, whose professional training 
included regular weightlifting. Inclusion 
criteria for the second experimental group, 
which consisted exclusively of LMM 
subjects, required being involved in regular 
(at least 4 times per week) aerobic training 
and not lifting weights. LMM subjects were 
selected from the local community. Levels 
of physical activity of the subjects were 
obtained through interview questions but 
not experimentally verified. 
 
None of the subjects in either group, as far 
as known, suffered from any disease that 
might interfere with H(e) metabolism. 
Subjects were not controlled for caloric 
intake, but the following restrictions on 
dietary supplements were enforced. In 
particular, subjects were not allowed to 
take (or have taken within the previous two 
months) any vitamin B or folate 
supplements (these lower H(e) levels), or 
protein or creatine monohydrate 
supplements (these would interfere with 
and artificially increase urine creatinine 
concentrations). Relevant personal details 
(anamnesis, training history) were collected 
using a questionnaire which the subjects 
completed in the presence of an exercise 
physiologist familiar with the 
questionnaire's contents and aims. 
Individuals with a family history of CVD, 
or who had self-reported hypertension, 
hypercholesterolemia, or diabetes were 
excluded from the study. 
 
Experimental design 
The study consisted of a single trial during 
which data were collected on the subjects' 
body composition to allow calculation of 
muscle mass, and to correlate these values 
with H(e) concentrations in plasma and 
urine. HMM subjects were given 
instructions on how to collect 24h-urine, 
and they were provided with 5-liter 
containers during a subject group meeting 
at their Bedford Police Station; LMM 
subjects were provided with the same 
during individual meetings prior to 
scheduling their experimental lab visits. 
Subjects were also reminded to refrain from 
taking vitamin B, folate, protein or creatine 
monohydrate dietary supplements, and 
were told to stay sufficiently hydrated 
when completing 24-hour urine collections 
and before reporting to the lab for 
bioimpedance body composition 
measurements. After having explained 
instructions and addressed eventual 
questions, subjects were told to schedule a 
visit to the lab facility between 10-12 am, 
during which they provided a fasting single 
venous blood sample. At that occasion they 
also delivered their containers with 24-hour 
urine collections. Subjects had been 
instructed to not exercise prior to blood, 
urine and bioimpedance body composition 
data collection. Exclusion criteria were: 
having taken dietary supplements, illness, 
or showing signs of dehydration, such as, 
for example, 24-hour urine collections 
<1,000 mL or containing <400 mg 
creatinine, as recommended by Flegg & 
Lakatta (11). 
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Anthropometrical measurements 
For both groups height, body mass, and age 
were recorded. In addition, body 
composition was measured using a bio-
electrical impedance analyzer (Biostat 1500, 
Bodystat Ltd., Douglas Isle of Man, British 
Isles). This method sends a minimal current 
through the body and measures its 
impedance. Recommendations to subjects 
before and during bioimpedance analysis 
included abstinence from caffeine and 
remaining sufficiently hydrated.  Lean 
body mass (LBM) was calculated by 
subtracting fat tissue mass from total body 
mass. Muscle mass was estimated from 
creatinine excretion as described later in 
this paper. 
 
Blood collection and analysis 
Subjects had to provide a single 10-mL 
sample of venous blood obtained from an 
antecubital vein using a disposable syringe. 
The sample was immediately transferred to 
pre-cooled 5-mL di-potassium 
ethylenediamine tetra-acetate (EDTA) 
polypropylene tubes. These tubes were 
then centrifuged for 5 minutes at 3,000 g. 
The plasma was pipetted into 1.5 mL 
Eppendorf cups and immediately frozen at 
-80°C until analysis. 
 
Blood samples were analyzed for plasma 
total homocyst(e)ine (H[e]), which is the 
sum of homocysteine and the 
homocysteinyl moieties of the disulfides 
homocystine and cysteine-homocysteine, 
whether free or bound to proteins (25, 26, 
44). All H(e) analyses were performed at, or 
according to procedures identical to those 
established by Malinow et al. (27). This is 
an automated method based on high-
pressure liquid chromatography (HPLC) 
with electrochemical detection, as 
previously described in detail (27). The 
within-assay coefficient of variation (cvi) of 
the method described above was 2.0% and 
the between-assay coefficient of variation 
(cvb) below 7.0%. 
 
Plasma samples were also analyzed for 
creatinine. Therefore we used a 
commercially available kit from Sigma (St. 
Louis, MO) for quantitative colorimetric 
analysis. This method was based on the 
color change that occurs when alkaline 
picrate is exposed to creatinine (Jaffé 
reaction) (5). 
 
Urine collection and analysis 
Subjects provided 24-hour samples of urine 
for analysis of urinary homocyst(e)ine 
(UH[e]) and creatinine (UCrt). Urine was 
collected in previously distributed 5-L 
plastic containers (Richardsons, Leicester, 
UK or similar), which were kept 
refrigerated during use. The container was 
then transported to the lab, the urine 
volume (UVol) recorded, mixed and two 
30-mL aliquots frozen and stored at -80 °C 
until analysis. UH(e) and UCrt were 
measured in 30 mL aliquots according to 
methods similar to those described above 
for plasma concentrations. 
 
UCrt excretion was used to predict muscle 
mass. The 24-hour creatinine excretion is an 
easily measurable and validated index of 
total muscle mass (38, 46). Because it has 
been demonstrated that per 18.5 kg of 
muscle, one gram of creatinine is excreted 
(7, 17), muscle mass can be estimated by the 
formula: 
 
Muscle mass in kg= 1.85 × mg creatinine 
excreted per day: body mass 
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Despite prior validation of estimating body 
mass on urinary creatinine excretion (11, 12, 
17, 38, 46), one limitation is that creatinine 
will also be derived from ingested muscle 
such as red meat, which means that ideally 
a meat-free diet for approximately 3 days 
prior to the testing should be required. 
However, because our estimations used 24-
hour samples of urine the possible effect of 
meals is attenuated (18). Therefore, we 
chose not to apply the fasting method. 
 
Calculation of renal clearance 
Because we measured H(e) and creatinine 
in both plasma and urine, it allows us to 
calculate clearance rates and renal function 
(39). The excretion rate of creatinine 
(EXRCrt) and homocyst(e)ine (EXRHe) were 
estimated as follows: 
 
EXRCrt= UCrt × UVol 
 
EXRHe= UH(e) × UVol 
 
The clearance rates of creatinine (CRCrt) and 
homocyst(e)ine (CRHe) were computed 
according to the knowledge that the 
excretion of a substance equals the urinary 
excretion of the substance divided by the 
plasma concentration of the substance (39): 
 
CRCrt =  EXRCrt × Crt-1 = (UCrt × 
UVol) × Crt-1 
 
CRHe = EXRHe × H(e)-1 = (UH(e) × UVol) × 
H(e)-1 
 
This, then also allows estimation of tubular 
resorption of creatinine (TRESCrt) and 
homocyst(e)ine (TRESHe) (39): 
 
TRESCrt = (CRCrt × Crt) - (UCrt × UVol) 
 
TRESHe = (CRHe × He) - (UHe × UVol) 
 
Statistical analysis 
Normal probability plot showed that date 
sets were normally distributed. Student's 
 
Table 1: Anthropometrical characteristics of the participants (high-muscle mass subjects vs. low-muscle 
mass subjects). Values represent means ± SD (N= 24, in each group). 
 
Variable High-Muscle Mass 
Group 
Low-Muscle Mass 
Group 
P-
value 
Age (yr) 
Height (cm) 
Body mass (kg) 
Body fat (%) 
Lean body mass (kg) 
Muscle mass (kg) 
BMI 
32.4 ± 2.5 
181.1 ± 2.6 
86.2 ± 11.0 
17.2 ± 4.0 
72.1 ± 2.9 
40.3 ± 15.9 
26.7 ± 2.8 
31.8 ± 2.4 
186.2 ± 4.2 
85.7 ± 9.8 
14.8 ± 2.6 
73.1 ± 3.5 
37.2 ± 11.4 
24.6 ± 2.6 
NS 
0.01 
NS 
0.03 
NS 
0.02 
0.03 
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two-sample t-test was anticipated to be 
appropriate. The t-test remains robust even 
with moderate departures from normality. 
In a recently completed study using similar 
outcome variables, the distribution of the 
levels of H(e) showed no radical departures 
from normality. If the dispersion of the data 
was strongly related to the mean, the t-test 
was applied to the log-transformed data. 
The Bonferroni correction (dividing alpha 
by the number of comparisons) was 
considered but rejected for a number of 
reasons, such as groups compared not 
being identical on all variables and because 
of a reluctance to inflate type II errors in 
order to decrease type I errors. To support 
the conclusions based on the t-test, the 
corresponding rank tests were also carried 
out. 
 
Pearson's correlation coefficient was used 
to assess the relationship between H(e) and 
indicators of muscle mass, being lean body 
mass and creatinine concentrations, 
respectively. The α-level was set a priori at 
0.05. Data analysis was completed using the 
Statistical Package for the Social Sciences, 
versions 13-17 for MS-Windows (SPSS Inc., 
Chicago, IL). Results are presented as 
means ± SD. 
 
RESULTS 
 
Body composition and estimation of muscle 
mass 
Twenty-four male subjects in each group 
successfully completed this trial. Their 
descriptive values are mentioned in Table 1. 
Mean body mass was 86.2 ± 11.0 kg in 
HMM subjects and 85.7 ± 9.8 kg in LMM 
subjects (not significant, [NS]). Although 
the HMM subjects had a mean BMI of 26.7 
± 2.8 their mean percentage of body fat was 
17.2 ± 4.0% and their muscle mass 40.3 ± 
15.9 kg, whereas the LMM group had a 
mean BMI of 24.6 ± 2.6 (P=0.03), body fat 
percentage of 14.8 ± 2.6 (P= 0.03), and a 
muscle mass of 37.2 ± 11.4 kg (P= 0.02). 
 
Homocyst(e)ine and creatinine values 
Mean plasma homocyst(e)ine levels were 
10.29 ± 2.9 nmol/mL in HMM and 10.02 ± 
2.4 nmol/mL in LMM (NS) (standard 
laboratory values: 5-15.9 nmol/mL) (Figure 
1). However, one HMM subject had 
elevated values at 16.90 nmol/mL. Urinary 
H(e) values averaged 9.95 ± 4.3 nmol/mL 
for HMM and 9.22 ± 2.9 nmol/mL for LMM 
(NS), respectively. 
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Figure 1. Plasma and urine homocyst(e)ine levels in 
high-muscle mass (white bars) vs. low-muscle mass 
(black bars) males. Values are means ± SD. 
*Significantly different P<0.05. 
 
Creatinine concentrations in plasma were 
for HMM: 1.3 ± 0.2 mg/dL and for LMM: 
1.2 ± 0.2 mg/dL (NS; normal: 0.9-1.4 
mg/dL), and urinary creatinine 
concentrations expressed per metric unit 
were 124.8 ± 49.7 mg/dL for HMM and 
103.1 ± 32.4 mg/dL (P= 0.03) for LMM; 
Total UCrt excretion per day for LMM was 
2,264 ± 542 mg/d and 1,729 ± 334 mg/d for 
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HMM (normal: 1,100-2,800 mg/d) (Figure  
2). 
Figure 2. Plasma and urine creatinine levels in 
weight-trained or high-muscle mass (white bars) vs. 
low-muscle mass (black bars) males. Values are 
means ± SD. *Significantly different P<0.05. 
 
Correlations between homocyst(e)ine, 
creatinine, and body composition 
Plasma H(e) correlated moderately with 
urine H(e) levels in both subject groups 
(HMM: r= 0.44, P= 0.03; LMM: r= 0.54, P= 
0.01). Plasma creatinine in HMM, however, 
did not significantly correlate with urinary 
creatinine. No significant correlations were 
found between plasma H(e) and creatinine 
in either group, whereas the urinary 
equivalents of both parameters were 
significantly correlated (HMM: r= 0.64, P= 
0.001; LMM: r= 0.67, P= 0.001). Plasma H(e) 
levels in either group were not significantly 
correlated with BMI (HMM: r= 0.50; LMM: 
r= 0.38), body mass (HMM: r= 0.35; LMM: 
r= 0.29), muscle (HMM: r= 0.02; LMM: r= 
0.34) or body fat (HMM: r= 0.26; LMM: r= 
0.28). Both urinary H(e) and creatinine 
levels showed trends towards weak 
correlations with body mass (r= 0.39, P= 
0.10 & r= 0.41, P= 0.08, respectively), but 
only in the HMM subjects. 
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Table 2: Overview of the contribution of renal function to H(e) and creatinine concentrations in high-
muscle mass subjects vs. low-muscle mass subjects. Values represent means ± SD (N= 24, in each group). 
 
Parameter High-Muscle Mass 
Group 
Low-Muscle Mass 
Group 
P-value 
Excretion Volume 
Homocyst(e)ine (μmol/d) 
Creatinine (g/d) 
Clearance Rate 
Homocyst(e)ine (mL/min) 
Creatinine (mL/min) 
Tubular Reabsorption 
Homocyst(e)ine (nmol/min) 
Creatinine (mg/min) 
 
18.1 ± 4.7 
2.3 ± 0.5 
 
1.2 ± 1.1 
120.9 ± 21.7 
 
<0.1 
1.4 ± 0.3 
 
15.6 ± 3.1 
1.7 ± 0.3* 
 
1.1 ± 0.8 
100.1 ± 16.2 
 
<0.1 
1.1 ± 0.2 
 
NS 
0.03 
 
NS 
NS 
 
NS 
NS 
*Significantly different LMM vs. LMM 
* 
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Renal clearance and tubular resorption 
Data of renal function are summarized in 
Table 2. The mean EXRCrt was 2.3 ± 0.5 g/d 
or 26.3 ± 5.0 mg · kg-1 · day-1 in HMM and 
1.7 ± 0.3 g/d or 20.2 ± 3.4 mg · kg-1 · day-1 in 
LMM (P= 0.03). CRCrt values were 120.9 ± 
21.7 mL/min and 100.1 ± 16.2 mL/min in 
HMM and LMM, respectively (NS), which 
was within normal laboratory ranges (90-
135 mL/min). The mean EXRH(e) and CRH(e) 
values were 18.1 ± 4.7 μmol/d and 1.2 ± 1.1 
mL/min, respectively in HMM, and 15.6 ± 
3.1 μmol/d and 1.1 ± 0.8 mL/min, 
respectively in LMM (NS). No significant 
group differences for TRESHe values were 
found. 
 
DISCUSSION 
 
With the exception of two HMM 
individuals who showed moderate 
hyperhomocyst(e)inemia' (between 16-30 
nmol/mL), all subjects had mean H(e) 
values which were within normal ranges 
and well in agreement with typical 
concentrations in healthy males reported by 
other researchers (6, 26, 43). 
 
H(e) is traditionally determined in plasma, 
but can also be measured in urine. This is 
not generally performed because of the 
difficulties with obtaining 24-hour 
collections of urine. In the present study we 
found that urinary H(e) concentrations 
correlated well with those in plasma. This 
finding is in agreement with existing 
literature. For example, Brattström et al. (6) 
found significant correlations between 
urine and plasma H(e) correlations of r= 
0.51 in athero-thrombotic patients and r= 
0.42 in controls (both, P<0.001), which is 
similar to what we found. 
 
Our initial hypothesis was that differences 
in H(e) levels might be attributed to 
differences in muscle mass. In this study, 
muscle mass was estimated based on 
urinary creatinine excretion. The total daily 
volume of excreted creatinine in urine was 
higher in the HMM than in the LMM, 
which is in line with expectations. Our 
further findings, in particular our 
observation of H(e) in either plasma or 
urine not being significantly correlated with 
muscle mass, body mass, or percentage of 
body fat, does not lend support to our 
hypothesis. It is therefore highly unlikely 
that muscle mass would represent an 
important factor in determining H(e) levels. 
 
Renal clearance is the volume of blood that 
is cleared of a particular substance per unit 
of time (39). It provides an approximation 
of glomerular filtration rate (GFR) and of 
renal function. GFR can theoretically be 
estimated in measuring the clearance of any 
chemical substance on the condition that it 
has a stable level in blood, and that it is 
freely filtered but not reabsorbed or 
secreted by the kidney. Tubular 
reabsorption then is the process by which 
solutes and water are removed from 
tubular fluid and transported back into the 
blood (39). In the present study, data for 
renal clearance rates and tubular resorption 
of both creatinine  and H(e) were within 
normal ranges. The absence of any 
significant differences for these parameters 
between the two subject groups suggests 
that our subjects had a clinically normal 
renal function, and that differences in 
muscle mass do not affect clearance of 
either H(e) or creatinine. We also note that 
our data suggest that tubular resorption of 
H(e) is almost nonexistent. This finding is 
in agreement with Arnadottir & Hultberg 
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(2) and with Wollesen et al. (49), who 
concluded that H(e) is ultrafiltrated in 
glomeruli, almost completely absorbed in 
tubuli, and degraded in kidney tissue by 
transmethylation and transsulfuration, and 
that healthy humans typically return as 
much H(e) to the circulation as is 
ultrafiltrated in glomeruli. 
 
It has been suggested before that 75% of 
H(e) production takes place in direct 
conjunction with the formation of creatine 
and creatinine (1, 32), but literature data are 
inconsistent. Some authors have found 
positive correlations between plasma 
creatinine and H(e) in patients with CHD 
and stroke (6, 20, 24), while others have not 
(49). Brattström and colleagues (6) have 
previously demonstrated that only in male 
and female patients with CVD they were 
able to perceive such a correlation between 
plasma creatinine and H(e), but not in their 
healthy control subgroups. If muscle mass 
would have been a major mediating factor 
of H(e), one would expect to find such a 
correlation in healthy subjects too. 
 
With the exception of anthropometric 
differences (mostly as a consequence of 
subjects being selected into either HMM or 
LMM groups), total creatinine excretion 
and urinary creatinine levels, no significant 
differences were found in metabolic 
parameters between the HMM and LMM 
subject groups. The absence of differences 
in H(e) as far as related to muscle mass 
seems to support the conclusions of 
Fukagawa et al. (13), and is also in 
agreement with Mora and colleagues (30). 
Fukagawa et al. (13) investigated the effect 
of remethylation of homocysteine in the 
liver in determining H(e) levels. During the 
process of remethylation homocysteine is 
salvaged by acquisition of a methyl group 
from N5-methyl-tetrahydrofolate in a 
vitamin B-12–dependent pathway or from 
betaine. Using ANCOVA, these authors 
adjusted remethylation for fat-free mass 
and muscle mass, respectively, and noted 
that only adjustment for fat-free mass 
attenuated gender-differences in H(e). In 
other words, fat-free mass, but not muscle 
mass, appeared to affect remethylation. 
Thus, similar to us, their findings too were 
unable to confirm the amount of muscle 
mass as a critical determinant in mediating 
H(e) levels as had been suggested 
previously (2, 6, 10, 32). 
 
Another consideration that is hard to join 
with the muscle mass/homocysteine 
hypothesis is that muscle mass typically 
decreases with advancing age, whereas 
homocysteine levels tend to increase. 
Certainly, there are other confounders 
involved in the process of aging, but it 
nevertheless adds even more arguments 
against than in support of the muscle mass-
homocysteine hypothesis. 
 
Because neither we, nor Fukagawa et al. 
(13), nor Mora et al. (30) have been able to 
confirm a muscle mass/homocysteine 
relationship, and since we were not even 
able to find a significant correlation 
between creatinine and H(e) in every 
subject, other explanations should be 
considered. Creatinine also represents an 
index of renal function, and its circulating 
levels and metabolism are influenced by 
renal and liver disease (12, 34). Potentially, 
it may be or may have been kidney function 
rather than muscle mass which was 
reflected in the relationship creatinine/H(e) 
which Brattström and colleagues (6) 
observed in patients with CVD. Based on 
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increased H(e) levels found in 
haemodialysis patients and chronic kidney 
disease patients (19, 23), it has, indeed, been 
argued that H(e) levels would depend on 
the level of renal function (23, 24, 26). 
 
Since muscle mass, contrary to our starting 
hypothesis, does not appear to be a 
determinant in H(e) levels in same-gender 
subjects, it is unlikely it would be in 
causing male vs. female differences in H(e) 
levels. The results from Fukagawa et al. (13) 
obtained in male vs. female subjects lend 
credence to this assumption. The most 
obvious confounder to present a challenge 
to the muscle/H(e) hypothesis when 
comparing homocysteine levels across 
gender, clearly are the major differences in 
sex steroid hormones (29). An abundant 
number of studies has now been able to 
demonstrate that H(e) concentrations are 
negatively correlated with estradiol levels 
(4, 9, 31, 41, 45, 50). Moreover, H(e) levels 
significantly decrease following four 
months of treatment with ethinyl estradiol 
and the anti-androgen cyproterone acetate 
in the male-to-female transsexuals, whereas 
they significantly went up in the female-to-
male transsexuals H(e) levels after two 
weeks of treatment with testosterone (16). 
Sex steroids may also play a role in same-
gender differences in H(e) levels related to 
different types of physical activity. For 
example, animal experiments have shown 
that testosterone significantly alters the 
formation and utilization of S-
adenosylmethionine, a key factor in the 
synthesis of H(e) (28). 
 
The authors recognize that today other 
perhaps more reliable techniques, such as 
notably CAT-scan, Magnetic Resonance 
Imaging (MRI), or Dual X-ray-Energy 
Absorptiometry (DEXA) (22), have become 
the method of choice for estimating muscle 
mass. However, this was not yet so at the 
time we commenced the present study, 
which took much longer to complete than 
expected due the difficulties in recruiting a 
sufficient number of LMM subjects weight-
matched for all HMM subjects. One reason 
for these difficulties was that aerobic 
athletes on the average are lighter than 
athletes or subjects who only engage in 
weight-training making it difficult to 
weight-match subjects from both groups. 
 
In the present study we did not make use of 
a methionine-loading test (1) mainly 
because of evidence suggesting that this 
method in people with the so-called 
'thermolabile' alternative form of one of the 
converting enzymes (N5,N10-
methylenetetrahydrofolate reductase might 
lead to considerable errors (15). The authors 
are aware of potential additional 
confounders, such as age, temperature, pH 
(low pH causes increased formation of 
creatinine), and an approximately 15% 
daily intra-individual variation in 
creatinine excretion (14, 21, 35). In addition, 
inter-individual differences in H(e) levels 
may be caused by the rate of remethylation 
in the liver. In remethylation, homocysteine 
is salvaged by acquisition of a methyl 
group from N5-methyl-tetrahydrofolate in 
a vitamin B-12–dependent pathway or from 
betaine. Other limitations are that, if one 
individual at the same time has a 20% 
higher creatinine production rate and 
clearance rate when compared to another 
individual, the creatinine levels of both 
individuals may very well be similar 
though they may reflect a thoroughly 
different muscle mass. 
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The results obtained from the present study 
suggest that: (a) our data do not support the 
existence of a causal relationship between 
the amount of muscle mass and H(e) levels 
in plasma or urine in healthy male 
volunteers; (b) plasma and urinary H(e) 
levels correlate well. 
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